|
|
|
| Research progress of adipokines in nonalcoholic fatty liver disease |
| SHI Xiangtian1 XU Yanan2 WANG Meng1 QIAO Tongshan1 QIAO Shan1 WANG Mancang1 OUYANG Xiaohui2 SU Xiulan2 |
1.Department of Hepatobiliary Surgery, Bayannur Hospital, Inner Mongolia Autonomous Regin, Bayannur 015002, China;
2.Clinical Medical Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Inner Mongolia Autonomous Regin, Hohhot 010050, China |
|
|
|
Abstract With the increasing prevalence of obesity related metabolic diseases in the world, the proportion of nonalcoholic fatty liver disease (NAFLD) in liver diseases is gradually increasing, and the disease brings related disabilities. Complications have brought a heavy burden to patients suffering from the disease and social medical care. Non-alcoholic steatohepatitis is the body’s glucose and fat metabolism disorder, systemic low-grade inflammation. Then pro-inflammatory and anti-inflammatory adipokines, as a hormone of secretion, is secreted by adipose tissue (AT) that compose the AT-liver axis. But the adipokines have different functions between the processes of inflammation and pro-inflammatory. It will be effective in liver transport, fat breakdown ability and liver fat deposition, and regulating the development of NAFLD. This article focuses on the expression level and mechanism of adiponectin, leptin, resistin, visfatin, retinol binding protein 4, and other adipokines in the progression of NAFLD disease. With the improvement of adipokines research and the follow-up of clinical research, new strategies and new ideas are provided for the treatment of adipokines in NAFLD disease.
|
|
|
|
|
|
[1] Muriana FJG，Millán-Linares MC，Sánchez-Margalet V. Nutritional modulation of leptin expression and leptin action in obesity and obesity-associated complications [J]. J Nutr Biochem，2021，89：108561. doi：10.1016/j.jnutbio.2020.108561.
[2] Phuengmaung P，Panpetch W，Singkham-In U，et al. Candida tropicalis Presence of on Biofilms Facilitated Biofilm Production and Dissemination：An Impact of Fungi on Bacterial Biofilms [J]. Front Cell Infect Microbiol，2021， 11：763239.
[3] Qu W，Ma T，Cai J，et al. Liver Fibrosis and MAFLD： From Molecular Aspects to Novel Pharmacological Strategies [J]. Front Med（Lausanne），2021，8（7）：761538.
[4] Landecho MF，Tuero C，Valentí V，et al. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk [J]. Nutrients，2019，11（11）：2664.
[5] Khan RS，Bril F，Cusi K，et al. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease [J]. Hepatology，2019，70（2）：711-724.
[6] Brown M，Dainty S，Strudwick N，et al. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface [J]. Mol Biol Cell，2020，31（23）：2597-2629.
[7] Lange M，Angelidou G，Ni Z，et al. AdipoAtlas： A reference lipidome for human white adipose tissue [J]. Cell Rep Med，2021，2（10）：100407.
[8] Park WY，Park J，Lee S，et al. PEX13 is required for thermogenesis of white adipose tissue in cold-exposed mice [J]. Biochim Biophys Acta Mol Cell Biol Lipids，2022，1867（1）：159046.
[9] Unamuno X，Gómez-Ambrosi J，Rodríguez A，et al. Adipokine dysregulation and adipose tissue inflammation in human obesity [J]. Eur J Clin Invest，2018，48（9）：e12997.
[10] Nakanishi T，Kagamizono K，Yokoyama S，et al. Dietary phytanic acid-induced changes in tissue fatty acid profiles in mice [J]. J Dairy Res，2020，87（4）：498-500.
[11] Li H，Sun H，Qian B，et al. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice [J]. J Bone Miner Res，2020，35（4）：738-752.
[12] Salvator H，Grassin-Delyle S，Brollo M，et al. Adiponectin Inhibits the Production of TNF-α，IL-6 and Chemokines by Human Lung Macrophages [J]. Front Pharmacol，2021，12：718929.
[13] Shabani P，Emamgholipour S，Doosti M. CTRP1 in Liver Disease [J]. Adv Clin Chem，2017，79（1）：1-23.
[14] Franchitto A，Carpino G，Alisi A，et al. The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy [J]. J Pediatr，2020，216：117-127.e2.
[15] Mavilia MG，Wu GY. Liver and serum adiponectin levels in non-alcoholic fatty liver disease [J]. J Dig Dis，2021， 22（4）：214-221.
[16] Dong Z，Zhuang Q，Ye X，et al. Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways [J]. Front Med （Lausanne），2020，7：546445.
[17] Eshaghian A，Khodarahmi A，Safari F，et al. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats [J]. Br J Nutr，2018，120（4）：393-403.
[18] Harris RBS. Consuming sucrose solution promotes leptin resistance and site specifically modifies hypothalamic leptin signaling in rats [J]. Am J Physiol Regul Integr Comp Physiol，2021，320（2）：R182-R194.
[19] Cheng W，Ndoka E，Maung JN，et al. NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity [J]. Nat Commun，2021，12（1）：5175.
[20] D’Incao RB，Tovo CV，Mattevi VS，et al. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients [J]. Obes Surg，2017，27（8）：2151-2158.
[21] Pan X，Zheng M，Zou T，et al. The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD：A Meta-Analysis [J]. Curr Mol Med，2018，18（2）：91-99.
[22] Lanaspa MA，Kuwabara M，Andres-Hernando A，et al. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism [J]. Proc Natl Acad Sci U S A，2018，115（12）：3138-3143.
[23] Zhu X，Jia X，Cheng F，et al. c-Jun acts downstream of PI3K/AKT signaling to mediate the effect of leptin on methionine adenosyltransferase 2B in hepatic stellate cells in vitro and in vivo [J]. J Pathol，2020，252（4）：423-432.
[24] Tang X，Li J，Xiang W，et al. Metformin increases hepatic leptin receptor and decreases steatosis in mice [J]. J Endocrinol，2016，230（2）：227-237.
[25] Zhang X，Liu Q，Zhang X，et al. FOXO3a regulates lipid accumulation and adipocyte inflammation in adipocytes through autophagy：Role of FOXO3a in obesity [J]. Inflamm Res，2021，70（5）：591-603.
[26] Franchitto A，Carpino G，Alisi A，et al. The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy [J]. J Pediatr，2020，216: 117-127.e2.
[27] Wen F，Shi Z，Liu X，et al. Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice [J]. Horm Metab Res，2021，53（2）：132-144.
[28] Gerner RR，Klepsch V，Macheiner S，et al. NAD metabolism fuels human and mouse intestinal inflammation [J]. Gut，2018，67（10）：1813-1823.
[29] Ma J，Zhao X，Zhang J，et al. Aldosterone may induce visfatin expression via the GR-ERK1/2 signal pathway in 3T3-L1 adipocytes [J]. Acta Biochim Biophys Sin（Shanghai），2019，51（3）：331-334.
[30] Heo YJ，Choi SE，Jeon JY，et al. κVisfatin Induces Inflammation and Insulin Resistance via the NF-B and STAT3 Signaling Pathways in Hepatocytes [J]. J Diabetes Res，2019，2019：4021623.
[31] Perduca M，Nicolis S，Mannucci B，et al. Human plasma retinol-binding protein （RBP4） is also a fatty acid-binding protein [J]. Biochim Biophys Acta Mol Cell Biol Lipids，2018，1863（4）：458-466.
[32] Wang X，Chen X，Zhang H，et al. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease [J]. Diabetes Metab，2020，46（2）：119-128.
[33] Blaner WS. Vitamin A signaling and homeostasis in obesity，diabetes，and metabolic disorders [J]. Pharmacol Ther，2019，197：153-178.
[34] Zhang Q，Wang J，Huang F，et al. Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages [J]. Dig Liver Dis，2021，53（5）：598-605.
[35] Gastaldelli A，Stefan N，H?覿ring HU. Liver-targeting drugs and their effect on blood glucose and hepatic lipids [J]. Diabetologia，2021，64（7）：1461-1479. |
|
|
|
